American Chemical Society--233rd National Meeting. CNS, cancer and cardiovascular targets. 25-29 March 2007, Chicago, IL, USA.
Rotella
David
D
Wyeth Research, Princeton, NJ 08543, USA. rotelld@wyeth.com
D000818:Animals; D001665:Binding Sites; D039481:CD11b Antigen / Q000187:drug effects / Q000378:metabolism; D018821:CD18 Antigens / Q000187:drug effects / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000188:drug therapy; D004224:Diterpenes / Q000737:chemistry / Q000494:pharmacology; D045785:Diterpenes, Clerodane; D016503:Drug Delivery Systems; D015195:Drug Design; D015507:Drugs, Investigational; D006801:Humans; D039041:Integrin alpha4beta1 / Q000187:drug effects; D008120:Lobeline / Q000494:pharmacology; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D010879:Piperazines / Q000138:chemical synthesis; D021281:Quantitative Structure-Activity Relationship; D043562:Receptors, G-Protein-Coupled / Q000187:drug effects / Q000502:physiology; D017473:Receptors, Opioid, kappa; D026941:Sodium Channel Blockers / Q000138:chemical synthesis / Q000737:chemistry; D050493:Vesicular Monoamine Transport Proteins / Q000037:antagonists & inhibitors; D010975:Platelet Aggregation Inhibitors
D039481:CD11b Antigen; D018821:CD18 Antigens; D004224:Diterpenes; D045785:Diterpenes, Clerodane; D015507:Drugs, Investigational; D039041:Integrin alpha4beta1; D008120:Lobeline; D010879:Piperazines; D043562:Receptors, G-Protein-Coupled; D017473:Receptors, Opioid, kappa; D026941:Sodium Channel Blockers; D050493:Vesicular Monoamine Transport Proteins; D010975:Platelet Aggregation Inhibitors; C470192:Mrgprx1 protein, mouse; C101789:SA 4503; C090499:salvinorin A